107
Views
2
CrossRef citations to date
0
Altmetric
Case Report

An Experience of Multiple Hematomas in a Coronavirus Disease-19 Patient Administered with ART-123 and Heparin

, , , , , , ORCID Icon, , & show all
Pages 207-211 | Published online: 24 May 2021

References

  • World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed March 20, 2021.
  • Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;10:1097.
  • Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
  • Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intern Care Med. 2020;46:1089–1098. doi:10.1007/s00134-020-06062-x
  • Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:1023–1026. doi:10.1111/jth.14810
  • Poterucha TJ, Libby P, Goldhaber SZ, et al. More than an anticoagulant: do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117:437–444. doi:10.1160/TH16-08-0620
  • Musokea N, Loa KB, Albano J, et al. Anticoagulation and bleeding risk in patients with COVID-19. Thromb Res. 2020;196:227–230. doi:10.1016/j.thromres.2020.08.035
  • Vincent JL, Francois B, Zabolotskikh I, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with Sepsis-Associated Coagulopathy. JAMA. 2019;321:1993–2002. doi:10.1001/jama.2019.5358
  • Levi M, Vincent JL, Tanaka K, et al. Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with Sepsis-Associated Coagulopathy. Crit Care Med. 2020;48(8):1140–1147. doi:10.1097/CCM.0000000000004426
  • Takahashi H, Shoko T, Kuriyama K, et al. Characteristic of the patients with hemorrhagic events after recombinant thrombomodulin administration for sepsis-induced DIC. KANTO J Jpn Assoc Acute Med. 2016;37(2):412–415.
  • Nakashima M, Kanamaru M, Umemura K, Tsuruta K. Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers. J Clin Pharmacol. 1998;38:40–44. doi:10.1002/j.1552-4604.1998.tb04375.x
  • Therapeutic Management of Adults With COVID-19. NIH COVID-19 treatment guidelines. Available from: https://www.covid19treatmentguidelines.nih.gov/therapeutic-management/. Accessed March 20, 2021.